Atara

ASH: With PhIII data in hand, Atara eyes a submission to treat a small but desperate group of transplant patients
Endpoints
Mon, 12/13/21 - 11:47 pm
ASH2021
Atara
tabelecleucel
Tab-cel
EBV
A remyelinating agent remains a distant hope
EP Vantage
Thu, 10/14/21 - 10:56 am
Atara
ATA188
remyelination
multiple sclerosis
MS
Atara Bio CEO: Company’s Momentum in Cell Therapy Should Continue in 2021
BioSpace
Wed, 01/20/21 - 11:25 pm
Atara
cell therapy
Bayer Leaps into CAR T-Cell Therapy Scene with Atara Biotherapeutics Collaboration
BioSpace
Mon, 12/7/20 - 10:28 am
Bayer
CAR-T
cell therapy
Atara
Upcoming events – Atara and Aslan await validating results
EP Vantage
Fri, 08/2/19 - 10:40 am
Atara
Tab-cel
ATA188
multiple sclerosis
Aslan
varlitinib
Atara Reports Initial Data for Multiple Sclerosis Candidate
Yahoo/Zacks.com
Mon, 07/1/19 - 10:18 am
Atara
ATA188
clinical trials
multiple sclerosis
Where Will Gilead Sciences Spend Its Cash?
Motley Fool
Tue, 05/7/19 - 10:03 am
Gilead Sciences
M&A
Atara
Exelixis
Atara brings another experienced investigator onto its off-the-shelf CAR-T quest in latest collaboration
Endpoints
Fri, 09/7/18 - 05:51 pm
Atara
CAR-T
cancer
Hot Atara snags licensing deal with leading cancer center
Bizjournals.com
Mon, 06/15/15 - 09:54 am
Atara
cancer
Memorial Sloan Kettering
7 Biotech Stocks Moving Off The UBS Healthcare Conference
Yahoo/Benzinga
Tue, 05/19/15 - 04:57 pm
biotech
UBS
AcelRx
Affirmed NV
Atara
Cerulean Pharma
Endo International
Esperion Therapeutics
Immune Design
Amgen spin-out on deck for IPO
Seeking Alpha
Fri, 10/10/14 - 11:42 am
Amgen
spinoffs
IPOs
Atara
IPO Preview: Atara Biotherapeutics
Seeking Alpha
Thu, 07/24/14 - 09:08 am
IPOs
Atara
Too Early To Tell For Atara Biotherapeutics IPO
Seeking Alpha
Wed, 07/23/14 - 10:41 am
Atara
IPOs
Amgen spinoff Atara cranks its Series B up to $52M
Fierce Biotech
Fri, 01/10/14 - 06:58 pm
Amgen
Atara
Series B
oncology
kidney disease